Man Group
SNDX icon

Man Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Man Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.25M Buy
182,016
+137,378
+308% +$2.99M 0.01% 1235
2025
Q4 		$938K Sell
44,638
-130,313
-74% -$2.27M ﹤0.01% 1691
2025
Q3 		$2.69M Sell
174,951
-53,216
-23% -$697K ﹤0.01% 1300
2025
Q2 		$2.14M Buy
228,167
+94,031
+70% +$1.03M ﹤0.01% 1387
2025
Q1 		$1.65M Buy
134,136
+12,597
+10% +$178K ﹤0.01% 1432
2024
Q4 		$1.61M Buy
+121,539
New +$2.08M ﹤0.01% 1377

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Man Group's SNDX Position: Q1 2026 in Review

Man Group increased its Syndax Pharmaceuticals (SNDX) stake by 308% in Q1 2026, buying an estimated $2.99M and bringing the position to 182,016 shares worth $4.25M. The position accounts for 0.01% of the portfolio, ranked #1235.

Man Group first reported a position in SNDX in Q4 2024 and has held it in 6 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Man Group held 182,016 shares of Syndax Pharmaceuticals worth $4.25M as of Q1 2026.
  • Man Group bought 137,378 Syndax Pharmaceuticals shares in Q1 2026, an estimated $2.99M.
  • Syndax Pharmaceuticals made up 0.01% of Man Group's portfolio in Q1 2026, its #1235 holding.
  • Man Group first reported a position in Syndax Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.